Published in Clin Microbiol Rev on April 01, 2016
Does the vaginal microbiota play a role in the development of cervical cancer? Transl Res (2016) 0.78
The Immune Response to Prevotella Bacteria in Chronic Inflammatory Disease. Immunology (2017) 0.77
Effect of Mycoplasma hominis and cytomegalovirus infection on pregnancy outcome: A prospective study of 200 Mongolian women and their newborns. PLoS One (2017) 0.75
Screening of Compounds against Gardnerella vaginalis Biofilms. PLoS One (2016) 0.75
Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Med (2016) 0.75
Lactobacilli Dominance and Vaginal pH: Why Is the Human Vaginal Microbiome Unique? Front Microbiol (2016) 0.75
Taxonogenomics and description of Vaginella massiliensis gen. nov., sp. nov., strain Marseille P2517(T), a new bacterial genus isolated from the human vagina. New Microbes New Infect (2016) 0.75
Ovarian cycling and reproductive state shape the vaginal microbiota in wild baboons. Microbiome (2017) 0.75
Eukaryotic protein glycosylation: a primer for histochemists and cell biologists. Histochem Cell Biol (2016) 0.75
The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment. Microbiome (2017) 0.75
Validation and Implementation of Clinical Laboratory Improvements Act (CLIA)-Compliant Whole Genome Sequencing in Public Health Microbiology Laboratory. J Clin Microbiol (2017) 0.75
Bacterial biota of women with bacterial vaginosis treated with lactoferrin: an open prospective randomized trial. Microb Ecol Health Dis (2017) 0.75
Vaginal Lactobacillus Inhibits HIV-1 Replication in Human Tissues Ex Vivo. Front Microbiol (2017) 0.75
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 20.49
Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med (1983) 16.63
Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A (2010) 12.39
Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med (2005) 11.23
Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol (1955) 11.15
Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med (1995) 8.89
Anaerobic bacteria in nonspecific vaginitis. N Engl J Med (1980) 6.74
Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet (2012) 6.33
Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol (2004) 4.60
Temporal dynamics of the human vaginal microbiota. Sci Transl Med (2012) 4.58
Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol (1983) 4.42
Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol (1988) 4.23
Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clin Infect Dis (2008) 3.90
Heretofore undescribed organism isolated from the genitourinary system. U S Armed Forces Med J (1953) 3.54
Vulvovaginal candidosis. Lancet (2007) 3.50
The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis (1993) 3.32
Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol (2007) 3.10
DIAGNOSIS OF HEMOPHILUS VAGINALIS VAGINITIS BY GRAM-STAINED SMEARS. Am J Obstet Gynecol (1965) 3.03
Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One (2012) 2.79
Anaerobic vaginosis (non-specific vaginitis): clinical, microbiological, and therapeutic findings. Lancet (1983) 2.75
Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol Reprod (1997) 2.74
Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One (2010) 2.62
The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis (2009) 2.56
Bacterial vaginosis. Clin Microbiol Rev (1991) 2.27
The vaginal microbiota and susceptibility to HIV. AIDS (2014) 2.24
A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis (2008) 2.09
Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity (2015) 2.05
An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol (2007) 2.04
Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod (1999) 2.00
Functional and phylogenetic characterization of Vaginolysin, the human-specific cytolysin from Gardnerella vaginalis. J Bacteriol (2008) 1.93
The microbiology of bacterial vaginosis. Am J Obstet Gynecol (1993) 1.79
Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci U S A (2015) 1.79
Colonization of second-trimester placenta parenchyma. Am J Obstet Gynecol (2008) 1.76
Evidence for a commensal, symbiotic relationship between Gardnerella vaginalis and Prevotella bivia involving ammonia: potential significance for bacterial vaginosis. J Infect Dis (1997) 1.71
Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol (2011) 1.69
Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol (2010) 1.69
A taxonomic study of Gardnerella vaginalis (Haemophilus vaginalis) Gardner and Dukes 1955. J Gen Microbiol (1980) 1.69
Methods for quantitative and qualitative evaluation of vaginal microflora during menstruation. Appl Environ Microbiol (1986) 1.67
Comparison of gram stain, DNA probe, and culture for the identification of species of Mobiluncus in female genital specimens. J Infect Dis (1985) 1.66
Characterization of a novel Atopobium isolate from the human vagina: description of Atopobium vaginae sp. nov. Int J Syst Bacteriol (1999) 1.64
Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J Clin Microbiol (2005) 1.60
Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women. Ann Intern Med (2008) 1.59
The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. J Infect Dis (2006) 1.55
Quantitative assessment of vaginal microflora during use of tampons of various compositions. Appl Environ Microbiol (1987) 1.50
The relationship between early concentrations of 25 blood proteins and cerebral white matter injury in preterm newborns: the ELGAN study. J Pediatr (2011) 1.49
Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod (2003) 1.48
Qualitative assessment of vaginal microflora during use of tampons of various compositions. Appl Environ Microbiol (1987) 1.47
Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard. Obstet Gynecol (2009) 1.46
The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS One (2014) 1.43
Characterization of some strains from human clinical sources which resemble "Leptotrichia sanguinegens": description of Sneathia sanguinegens sp. nov., gen. nov. Syst Appl Microbiol (2001) 1.43
Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model. J Infect Dis (2014) 1.43
Pathogenesis of abnormal vaginal bacterial flora. Am J Obstet Gynecol (2000) 1.42
Guiding the vaginal microbicide trials with biomarkers of inflammation. J Acquir Immune Defic Syndr (2004) 1.42
Maternal microbe-specific modulation of inflammatory response in extremely low-gestational-age newborns. MBio (2011) 1.42
Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Clin Vaccine Immunol (2007) 1.41
Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect Immun (2006) 1.40
History and review of bacterial vaginosis. Am J Obstet Gynecol (1993) 1.36
Detection of Atopobium vaginae in postmenopausal women by cultivation-independent methods warrants further investigation. J Clin Microbiol (2004) 1.35
Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes. Microbiology (2009) 1.35
Drawing the line between commensal and pathogenic Gardnerella vaginalis through genome analysis and virulence studies. BMC Genomics (2010) 1.34
The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol (2013) 1.33
Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations. Am J Obstet Gynecol (2013) 1.33
Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Dis (2006) 1.32
New etiologic agent in nonspecific bacterial vaginitis. Science (1954) 1.30
Prevalence and abundance of uncultivated Megasphaera-like bacteria in the human vaginal environment. Appl Environ Microbiol (2008) 1.29
Quantitative studies of vaginal bacteria. Genitourin Med (1986) 1.28
Elevated concentrations of inflammation-related proteins in postnatal blood predict severe developmental delay at 2 years of age in extremely preterm infants. J Pediatr (2011) 1.28
Gram-positive anaerobic cocci--commensals and opportunistic pathogens. FEMS Microbiol Rev (2012) 1.27
Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion. J Acquir Immune Defic Syndr (2014) 1.23
Reservoir of four organisms associated with bacterial vaginosis suggests lack of sexual transmission. J Clin Microbiol (1990) 1.22
The aetiology of bacterial vaginosis. J Appl Microbiol (2011) 1.22
A commensal symbiosis between Prevotella bivia and Peptostreptococcus anaerobius involves amino acids: potential significance to the pathogenesis of bacterial vaginosis. FEMS Immunol Med Microbiol (1998) 1.21
Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. MBio (2011) 1.21
Gardnerella biofilm involves females and males and is transmitted sexually. Gynecol Obstet Invest (2010) 1.20
Understanding vaginal microbiome complexity from an ecological perspective. Transl Res (2012) 1.19
Nugent score related to vaginal culture in pregnant women. Obstet Gynecol (2001) 1.19
Early postnatal blood concentrations of inflammation-related proteins and microcephaly two years later in infants born before the 28th post-menstrual week. Early Hum Dev (2011) 1.18
The association of Mycoplasma hominis, Ureaplasma urealyticum and Mycoplasma genitalium with bacterial vaginosis: observations on heterosexual women and their male partners. Int J STD AIDS (2000) 1.16
Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review. Obstet Gynecol Surv (2010) 1.16
Bacterial vaginosis (BV) candidate bacteria: associations with BV and behavioural practices in sexually-experienced and inexperienced women. PLoS One (2012) 1.16
Gardnerella vaginalis and anaerobic bacteria in the etiology of bacterial (nonspecific) vaginosis. Scand J Infect Dis Suppl (1983) 1.15
Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle. Microbiome (2014) 1.13
The microbiota of the vagina and its influence on women's health and disease. Am J Med Sci (2012) 1.11
Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J Infect Dis (2014) 1.10
Quantitative microbiologic models for preterm delivery. J Clin Microbiol (2003) 1.10
Molecular cloning and characterization of an adherence-related operon of Mycoplasma genitalium. J Bacteriol (1995) 1.10
Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol (2004) 1.09
Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol (2005) 1.08
Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women. PLoS One (2012) 1.08
Inflammation-initiating illnesses, inflammation-related proteins, and cognitive impairment in extremely preterm infants. Brain Behav Immun (2013) 1.07
Epidemiology of bacterial vaginosis. Am J Obstet Gynecol (1993) 1.07
Genomic sequence analysis and characterization of Sneathia amnii sp. nov. BMC Genomics (2012) 1.07
More than meets the eye: associations of vaginal bacteria with gram stain morphotypes using molecular phylogenetic analysis. PLoS One (2013) 1.07
Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis. Microbiome (2013) 1.04
Ethnic differences of polymorphisms in cytokine and innate immune system genes in pregnant women. Obstet Gynecol (2004) 1.02
Ureaplasma urealyticum-induced production of proinflammatory cytokines by macrophages. Pediatr Res (2000) 1.01
Two-hit model of brain damage in the very preterm newborn: small for gestational age and postnatal systemic inflammation. Pediatr Res (2012) 0.99
Among pregnant women with bacterial vaginosis, the hydrolytic enzymes sialidase and prolidase are positively associated with interleukin-1beta. Am J Obstet Gynecol (2007) 0.96
The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert. Sex Transm Infect (2013) 0.96
Relationship of abnormal vaginal flora, proinflammatory cytokines and idiopathic infertility in women undergoing IVF. J Reprod Med (2001) 0.96